Aldesleukin, also known as recombinant interleukin-2 (IL-2), is a cytokine that plays a crucial role in the immune response, particularly in the activation and proliferation of T cells and natural killer (NK) cells. It is produced using recombinant DNA technology and is primarily used in the treatment of certain cancers, such as metastatic melanoma and renal cell carcinoma. Aldesleukin is characterized by its ability to enhance the body’s immune response against tumors, making it a key component in immunotherapy. The substance is typically administered via subcutaneous or intravenous injection, and its pharmacological effects include promoting lymphocyte growth and differentiation. Common side effects may include flu-like symptoms, hypotension, and potential organ toxicity, necessitating careful monitoring during treatment. Aldesleukin's mechanism of action involves binding to the IL-2 receptor on immune cells, leading to a cascade of signaling events that enhance immune function. Overall, Aldesleukin represents a significant advancement in cancer therapy, leveraging the body's immune system to combat malignancies.

Aldesleukin

102524-44-7: Aldesleukin, also known as recombinant interleukin-2 (IL-2), is a cytokine that plays a crucial role in the immune response, particularly in the activation and proliferation of T cells and natural killer (NK) cells. It is produced using recombinant DNA technology and is primarily used in the treatment of certain cancers, such as metastatic melanoma and renal cell carcinoma. Aldesleukin is characterized by its ability to enhance the body’s immune response against tumors, making it a key component in immunotherapy. The substance is typically administered via subcutaneous or intravenous injection, and its pharmacological effects include promoting lymphocyte growth and differentiation. Common side effects may include flu-like symptoms, hypotension, and potential organ toxicity, necessitating careful monitoring during treatment. Aldesleukin's mechanism of action involves binding to the IL-2 receptor on immune cells, leading to a cascade of signaling events that enhance immune function. Overall, Aldesleukin represents a significant advancement in cancer therapy, leveraging the body's immune system to combat malignancies.

<p>Interleukin-2 is a cytokine that is produced by activated T cells, natural killer cells, and monocytes. It plays an important role in the immune system and has been shown to be effective in treating bowel disease, polymerase chain reaction (PCR), optical sensor, disease activity, antitumor response, il-2 receptor, interleukin-2 biological properties, infectious diseases. Interleukin-2 is used as an active form of therapy for patients with renal cell cancer or autoimmune diseases. In addition to its immune stimulating effects, it has potent antitumor activity. Interleukin-2 can also be used in combination with other drugs such as interferon alfa-2b to treat AIDS patients.</p>

CAS 102524-44-7

Aldesleukin

Interleukin-2

Ref: 3D-FI37905